International Stem Cell Corporation (ISCO)

International Stem Cell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1	1	1	0	1	4
Market Cap Growth	144.71%	72.20%	31.13%	-65.56%	-61.94%	35.73%
Enterprise Value	8	8	8	8	9	11
Last Close Price	0.17	0.14	0.08	0.06	0.18	0.47
PS Ratio	0.15	0.12	0.07	0.06	0.18	0.53
PB Ratio	16.20	4.67	1.76	4.39	-6.55	-13.15
P/FCF Ratio	-	-	-	0.59	4.35	-
P/OCF Ratio	-	140.08	50.06	0.53	4.34	-
EV/Sales Ratio	0.89	0.91	0.83	0.97	1.15	1.59
EV/EBITDA Ratio	15.09	-	54.52	-	267.74	-
EV/FCF Ratio	-51.90	-	-	8.92	28.31	-
Debt / Equity Ratio	41.91	15.55	10.38	36.97	-19.43	-14.14
Debt / EBITDA Ratio	6.44	6.87	6.62	-	8.78	-
Debt / FCF Ratio	-	-	-	4.92	12.92	-
Net Debt / Equity Ratio	30.80	11.42	7.05	22.92	-16.06	-13.54
Net Debt / EBITDA Ratio	-58.79	-57.08	18.91	-5.52	100.94	-2.77
Net Debt / FCF Ratio	-16.27	-78.29	-17.06	3.05	10.67	-2.95
Asset Turnover	1.73	1.82	1.72	1.48	1.62	1.40
Inventory Turnover	2.64	3.03	3.12	2.40	2.55	2.79
Quick Ratio	0.34	0.38	0.49	0.45	0.34	0.24
Current Ratio	0.76	0.75	0.76	0.73	0.64	0.55
Return on Equity (ROE)	-256.38%	-137.05%	-86.54%	-	-	-
Return on Assets (ROA)	-2.81%	-3.34%	-0.80%	-7.87%	-2.27%	-20.41%
Return on Capital Employed (ROCE)	-288.10%	-111.20%	-14.00%	-118.80%	-36.60%	-252.40%
Earnings Yield	-28.07%	-37.30%	-32.12%	-26.40%	-22.97%	-23.75%
FCF Yield	-11.68%	-3.12%	-23.51%	171.08%	22.97%	-34.87%
Buyback Yield / Dilution	-	-	-	-	-2.19%	-3.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.